drugset / Trial / NCT01991951

Short Term Warfarin Therapy for Radiofrequency Catheter Ablation of Atrial Fibrillation

NCT01991951

Unknown 520 enrolled Korea University Anam Hospital
RandomizedSingle-groupOpen-labelTreatment

Summary

We hypothesized that in patients with low CHADS-VASc score (2 or \< 2), there is no difference in thromboembolic or bleeding events between patients with short term warfarin therapy (2 weeks after catheter ablation) and conventional therapy (3 weeks before and 8 weeks after procedure).

Timeline

Start
2013-07
Primary completion
2015-07
Completion
2017-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Warfarin Small molecule

Indications